RTW Biotech Opportunities (LON:RTW – Get Free Report) reached a new 52-week high on Saturday . The stock traded as high as GBX 1.61 ($0.02) and last traded at GBX 1.61 ($0.02), with a volume of 3115999 shares traded. The stock had previously closed at GBX 1.59 ($0.02).
RTW Biotech Opportunities Stock Performance
The firm has a fifty day simple moving average of GBX 1.46 and a 200 day simple moving average of GBX 1.29. The company has a market cap of £5.27 million, a PE ratio of -6.19 and a beta of 0.60.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Further Reading
- Five stocks we like better than RTW Biotech Opportunities
- What is a Special Dividend?
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- 3 Best Fintech Stocks for a Portfolio Boost
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
